Determination of the Main Risk Factors for Benzodiazepine Dependence Using a Multivariate and Multidimensional Approach

Comprehensive Psychiatry

Volumn 45, Issue 2, 2004, Pages 88-94

  Kan, Cornelis C ^a   Hilberink, Sander R ^b   Breteler, Marinus H M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; DISEASE SEVERITY; DRUG ABUSE; DRUG DEPENDENCE; DRUG HALF LIFE; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTPATIENT; RISK ASSESSMENT; SELF HELP; WITHDRAWAL SYNDROME;

EID: 1542514000     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2003.12.007     Document Type: Article

References (34)

1. Barnas C, Whitworth AB, Fleischhacker WW. Are patterns of benzodiazepine use predictable? A follow-up study of benzodiazepine users. Psychopharmacology (Berl) 1993;111:301-305.
2. Bixler EO, Kales JD, Kales A, Jacoby JA, Soldatos CR. Rebound insomnia and elimination half-life: assessment of individual subject response. J Clin Pharmacol 1985;25:115-124.
3. Busto U, Sellers EM, Naranjo CA, Cappell H, Sanchez Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986;315:854-859.
4. Golombok S, Higgitt A, Fonagy P, Dodds S, Saper J, Lader M. A follow-up study of patients treated for benzodiazepine dependence. Br J Med Psychol 1987;60:141-149.
5. Hallstrom C, Lader M. Benzodiazepine withdrawal phenomena. Int Pharmacopsychiatry 1981;16:235-244.
6. Hellerstein DJ, Flansaas DM, Zweben-Howland LD, Samstag LW. A clinical profile of patients affected by state regulation of benzodiazepine prescriptions. Hosp Community Psychiatry 1994;45:362-365
7. Holton A, Riley P, Tyrer P. Factors predicting long-term outcome after chronic benzodiazepine therapy. J Affect Disord 1992;24:245-252.
8. Kales A, Scharf MB, Kales JD, Soldatos CR. Rebound insomnia: A potential hazard following withdrawal of certain benzodiazepines. JAMA 1979;241:1692-1695.
9. Ias-Cuevas C, Sanz EJ, de la Fuente JA, Padilla J, Berenguer JC. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 2000;95:245-250.
10. Linden M, Bar T, Geiselmann B. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions. Psychol Med 1998;28:721-729.
11. Murphy SM, Tyrer P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. Br J Psychiatry 1991;158:511-516.
12. Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines: 1. Effects of abrupt discontinuation. Arch Gen Psychiatry 1990;47:899-907.
13. Schweizer E, Case WG, Rickels K. Benzodiazepine dependence and withdrawal in elderly patients. Am.J.Psychiatry 1989;146:529-531.
14. Schweizer E, Rickels K, Case WG, Greenblatt DJ. Long-term therapeutic use of benzodiazepines: 11. Effects of gradual taper. Arch Gen Psychiatry 1990;47:908-915.
15. Schweizer E, Rickels K, De Martinis N, Case G, Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychol Med 1998;28:713-720.
16. Tyrer P, Rutherford D, Huggett T. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1981;1:520-522.
17. Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1983;1:1402-1406.
18. Joughin N, Tata P, Collins M, Hooper C, Falkowski J. In-patient withdrawal from long-term benzodiazepine use. Br J Addict 1991;86:449-455.
19. Nicholas D, Hammond SM. Personality characteristics of long-term benzodiazepine users. Pers Individ Differ 1992;13:221-223.
20. Holm L, Bergman H, Borg S. Personality characteristics of patients with exclusive abuse of sedative-hypnotic drugs. Psychol Rep 1982;51:899-903.
21. Rickels K, Case GW, Winokur A, Swenson C. Long-term benzodiazepine therapy: benefits and risks. Psychopharmacol Bull 1984;20:608-615.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Ed 3. Rev). Washington, DC: American Psychological Association, 1987
23. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders: DSM-IV (Ed. 4). Washington, DC: American Psychological Association, 1994
24. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: WHO, 1992.
25. Kan CC, Breteler MHM, van der Ven AHGS, Zitman FG. An evaluation of the DSM-III-R and ICD-10 benzodiazepine dependence criteria using Rasch modelling. Addiction 1998;93:349-359.
26. Kan CC, Breteler MHM, Timmermans EAY, van der Ven AHGS, Zitman FG. Scalability, reliability and validity of the Benzodiazepine Dependence Self-Report Questionnaire in outpatient benzodiazepine users. Compr Psychiatry 1999;40:283-291.
27. Kan CC, Breteler MH, van der Ven AH, Zitman FG. Cross-validation of the Benzodiazepine Dependence Self-Report Questionnaire in outpatient benzodiazepine users. Compr Psychiatry 2001;42:433-439.
28. Kan CC, van der Ven AH, Breteler MH, Zitman FG. Latent trait standardization of the Benzodiazepine Dependence Self-Report Questionnaire using the Rasch scaling model. Compr Psychiatry 2001;42:424-432.
29. Wolf B, Griffiths RR. Physical dependence on benzodiazepines: differences within the class. Drug Alcohol Depend 1991;29:153-156.
30. Giel R, Nienhuis FJ. SCAN: Vragenschema"s voor de klinische beoordeling in de neuropsychiatrie. Geneva, Switzerland: World Health Organization, 1992.
31. Janca A, Ustun TB, Sartorius N. New versions of World Health Organization instruments for the assessment of mental disorders. Acta Psychiatr Scand 1994;90:73-83.
32. Arrindell WA, Ettema H. Dimensionele structuur, betrouwbaarheid en validiteit van de Nederlandse bewerking van de Symptom Checklist (SCL-90): Gegevens gebaseerd op een fobische en een "normale" populatie. Nederlands Tijdschr Psychol Grensgebieden 1981;36:77-108.
33. Kan CC, Breteler MHM, Zitman FG. High prevalence of benzodiazepine dependence in outpatient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand 1997;96:85-93.
34. Kan CC, Breteler MH, van der Ven AH, Timmermans MA, Zitman FG. Assessment of benzodiazepine dependence in alcohol and drug dependent outpatients: a research report. Subst Use Misuse 2001;36:1085-1109.